EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Glycyrrhizic Acid Class Compounds in Immune Checkpoint Inhibitor Therapy: Stereochemistry, Mechanistic Hypotheses, and Protection Against Immune-Related Organ Injury

Jie Li iD, Baojian Li, Ying Gao, Boshen Zhao, Jasur Kasim iD, Nanqi Shao iD, Zheng Gao, Zhan Liu, Zhongxing Song, Yinglai Yang, Jianguang Li

International Journal of Molecular Sciences · 07.11.2026 · 27 (21) · 9987

DOI: 10.3390/ijms27219987 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.11.2026. Verfasst von Jie Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Science and Innovation Center of Xinjiang Second Medical College, Karamay 834000, China. Hauptthemen laut MEDLINE: Glycyrrhizic Acid, Immune Checkpoint Inhibitors, Chemical and Drug Induced Liver Injury, Neoplasms. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karamay Science and Technology Plan Project, Xinjiang Second Medical College, Liver Disease Pathogenesis and Prevention Research Innovation Team.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycyrrhizic acid class compounds are used empirically for checkpoint inhibitor-induced liver injury (ChILI), but their effects on antitumour efficacy remain uncertain. This narrative review examines isomer-specific pharmacology, clinical evidence and the candidate mechanisms proposed for this class, of which the high-mobility group box 1 (HMGB1) axis is the most developed. In a propensity-score-matched cohort of 229 patients, magnesium isoglycyrrhizinate (MgIG) plus corticosteroids was associated with higher day-10 alanine aminotransferase normalization than corticosteroids alone (30.7% versus 17.4%). A single-arm study of 67 patients reported study-defined liver injury in 9.0% during prophylaxis. Neither study reported antitumour efficacy or established causal clinical benefit. Modulating extracellular HMGB1 might reduce organ inflammation while altering tumor immunosuppression. However, neither direct HMGB1 engagement by MgIG nor a causal contribution of HMGB1 to ChILI was established in the identified literature. HMGB1 can also support antitumour immune priming; its net effect depends on redox state, tissue and timing. The corresponding 18α aglycone shows no measurable inhibition of 11β-hydroxysteroid dehydrogenase type 2 up to 20 µM in vitro, which does not establish clinical safety. Controlled trials should assess liver injury, corticosteroid exposure, antitumour outcomes and electrolyte safety together; routine prophylaxis is not supported.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycyrrhizic AcidImmune Checkpoint InhibitorsChemical and Drug Induced Liver InjuryNeoplasmsHumansHMGB1 ProteinAnimals

Stichwörter der Autor:innen

HMGB1glycyrrhizic acidimmune checkpoint inhibitorimmune-related adverse eventslicoricemagnesium isoglycyrrhizinate

Substanzen

Glycyrrhizic AcidImmune Checkpoint InhibitorsHMGB1 Protein

Autor:innen und Institutionen

  • Science and Innovation Center of Xinjiang Second Medical College, Karamay 834000, China.
  • School of Pharmacy, Xinjiang Second Medical College, Karamay 834000, China.

ORCID-Profile: Jie Li, Jasur Kasim, Nanqi Shao

Förderung

  • Karamay Science and Technology Plan Project
  • Xinjiang Second Medical College
  • Liver Disease Pathogenesis and Prevention Research Innovation Team
  • Innovative Team for Bioactive Components and Pharmacological Mechanisms of Apocynum venetum Leaves

Zitieren

APA

Li, J., Li, B., Gao, Y., Zhao, B., Kasim, J., Shao, N., Gao, Z., Liu, Z., Song, Z., Yang, Y., & Li, J. (2026). Glycyrrhizic Acid Class Compounds in Immune Checkpoint Inhibitor Therapy: Stereochemistry, Mechanistic Hypotheses, and Protection Against Immune-Related Organ Injury. International Journal of Molecular Sciences, 27(21), 9987. https://doi.org/10.3390/ijms27219987

Vancouver

Li J, Li B, Gao Y, Zhao B, Kasim J, Shao N, et al. Glycyrrhizic Acid Class Compounds in Immune Checkpoint Inhibitor Therapy: Stereochemistry, Mechanistic Hypotheses, and Protection Against Immune-Related Organ Injury. International Journal of Molecular Sciences. 2026;27(21):9987. doi:10.3390/ijms27219987

BibTeX
@article{Li2026,
  author = {Li, Jie and Li, Baojian and Gao, Ying and Zhao, Boshen and Kasim, Jasur and Shao, Nanqi and Gao, Zheng and Liu, Zhan and Song, Zhongxing and Yang, Yinglai and Li, Jianguang},
  title = {Glycyrrhizic Acid Class Compounds in Immune Checkpoint Inhibitor Therapy: Stereochemistry, Mechanistic Hypotheses, and Protection Against Immune-Related Organ Injury},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9987},
  doi = {10.3390/ijms27219987}
}
Kostenlos starten →